Viking Therapeutics, Inc. VKTX 深 沪
已收盘 02-06 16:00:00 美东时间
28.44
+2.150
+8.18%
华盛通- 最 高28.47
- 今 开27.51
- 成交量 369.47万股
- 最 低 26.89
- 昨 收 26.29
- 总市值 32.15亿
- 52周最高 43.15
- 市盈率 静 --
- 换手率 3.27%
- 52周最低 18.92
- 委 比 -86.04%
- 总股本 1.13亿
- 历史最高 99.41
- 量 比 1.04
- 振 幅 6.01%
- 历史最低 0.88
- 每 手 1
- 风险率 4.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stocks Drop, Energy Sector Rises As Crude Eyes 6th Day Of Gains: What's Moving Markets Wednesday?
Wall Street retreated Wednesday as weakness in technology and financial stocks dragged major indexes lower, with investors remaining cautious ahead of a closely watched Supreme Court ruling on the legality of President Donald Trump's tariffs.
01-15 02:25
Here's How Much $100 Invested In Viking Therapeutics 10 Years Ago Would Be Worth Today
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 10 ...
01-07 07:45
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- USA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have...
2025-12-31 21:07
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 y...
2025-12-25 22:02
What's Up With The Jump In Viking Therapeutics Stock?
Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from the wider excitement in obesity treatment area and the recent positive momentum after major clinical trial developments.
2025-12-05 03:57
3 Weight-Loss Drug Stocks To Consider For 2026
The global weight loss drug market, perhaps ironically, is growing like gangbus...
2025-11-22 02:58
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
Canaccord Genuity Maintains Buy on Viking Therapeutics, Raises Price Target to $107
Canaccord Genuity analyst Edward Nash maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and raises the price target from $106 to $107.
2025-11-12 21:09
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils
Zoom Communications is a good company, Cramer says. Still, he advises, "take a pass." Plus: Viking Therapeutics, Profrac and Altria.
2025-11-05 21:33
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
2025-10-30 14:22
